|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2003-11-25
|
|
pubmed:abstractText |
Portal hypertension in cirrhosis is the result of increased intrahepatic vascular resistance to portal outflow as well as increased portal tributary blood flow. The angiotensin II type 1 receptor antagonist losartan has been suggested as a portal pressure-lowering drug in patients with cirrhosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0014-2972
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1006-12
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14636305-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:14636305-Animals,
pubmed-meshheading:14636305-Antihypertensive Agents,
pubmed-meshheading:14636305-Blood Pressure,
pubmed-meshheading:14636305-Cardiac Output,
pubmed-meshheading:14636305-Hemodynamics,
pubmed-meshheading:14636305-Hypertension, Portal,
pubmed-meshheading:14636305-Liver Cirrhosis, Experimental,
pubmed-meshheading:14636305-Losartan,
pubmed-meshheading:14636305-Male,
pubmed-meshheading:14636305-Microspheres,
pubmed-meshheading:14636305-Portal Pressure,
pubmed-meshheading:14636305-Rats,
pubmed-meshheading:14636305-Rats, Sprague-Dawley,
pubmed-meshheading:14636305-Splanchnic Circulation,
pubmed-meshheading:14636305-Vascular Resistance
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.
|
|
pubmed:affiliation |
Department of Internal Medicine I, University of Bonn, Bonn, Germany. jheller@uni-bonn.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
